Contents
Current HIV Research, Volume 12 - Number 5
Drug Resistance Mutations from Whole Blood Proviral DNA Among Patients on Antiretroviral Drugs in Zimbabwe
, 12(5): 309 - 316Benjamin Chimukangara, Lovemore Gwanzura, Rebecca Mitchell, David Katzenstein and Collen Masimirembwa
DOI: 10.2174/1570162X12666141017100733
Drug Resistance Mutations from Whole Blood Proviral DNA Among Patients on Antiretroviral Drugs in Zimbabwe
Chronic, Highly Productive HIV Infection in Monocytes During Supportive Culture
, 12(5): 317 - 324Manisha Saini and Mary Jane Potash
DOI: 10.2174/1570162X1205141121100659
Chronic, Highly Productive HIV Infection in Monocytes During Supportive Culture
A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir
, 12(5): 325 - 338Bawneet K. Narang, Gurpreet K. Grewal, Subhajit Roy, Jitender Bariwal, Manish K. Gupta and Ravindra K. Rawal
DOI: 10.2174/1570162X12666140807150753
A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir
Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients
, 12(5): 339 - 346S. Bonora, A. Calcagno, O. Vigano, P. Bigliano, L. Marinaro, E. Colella, G. Orofino, L. Trentini, M.C. Tettoni, A. D'Avolio, S. Mercadante, M. Galli, G. Di Perri and S. Rusconi
DOI: 10.2174/1570162X12666140807151616
Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients
2´,3´-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication
, 12(5): 347 - 358Julieta Schachter, Ana Luiza Chaves Valadao, Renato Santana Aguiar, Victor Barreto-de-Souza, Atila Duque Rossi, Pablo Ricardo Arantes, Hugo Verli, Paula Gabriela Quintana, Norton Heise, Amilcar Tanuri, Dumith Chequer Bou-Habib and Pedro Muanis Persechini
DOI: 10.2174/1570162X12666140826105824
2´,3´-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication
Improved Survival with Co-Trimoxazole Prophylaxis among People Living with HIV/AIDS Who Initiated Antiretroviral Treatment in Henan Province, China
, 12(5): 359 - 365Qian Zhu, Liming Wang, Wen Lin, Marc Bulterys, Wenjie Yang, Dingyong Sun, Zhaolin Cui, Jonathan Kaplan, Nora Kleinman, Xiaoyu Wei, Jessica Chung and Zhe Wang
DOI: 10.2174/1570162X1205141121102155
Improved Survival with Co-Trimoxazole Prophylaxis among People Living with HIV/AIDS Who Initiated Antiretroviral Treatment in Henan Province, China
The Combination of Pill Count and Self-Reported Adherence is a Strong Predictor of First-Line ART Failure for Adults in South Africa
, 12(5): 366 - 375Peng Wu, Brent A. Johnson, Jean B. Nachega, Baohua Wu, Claudia E. Ordonez, Anna Q. Hare, Rachel Kearns, Richard Murphy, Henry Sunpath and Vincent C. Marconi
DOI: 10.2174/1570162X1205141121102501
The Combination of Pill Count and Self-Reported Adherence is a Strong Predictor of First-Line ART Failure for Adults in South Africa
Webmaster Contact: info@benthamscience.org